Form D · Pharmaceuticals

SteadMed Medical, LLC

Fort Worth, TX · CIK 0001516878

Offering snapshot reported Jun 28, 2011 · SEC filing

Reported sold
$3.08M
Offering amount: $6M
Investors reported
30
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Mar 21, 2011
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.54M$3.08MMar 31, 2011: $150,000.00Mar 31, 2011Jun 28, 2011: $3,075,000.00Jun 28, 2011

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$150,000 → $3,075,000
  • Reported investors1 → 30

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 28, 2011Amendment$3,075,000$2,925,000vs Mar 31, 201130SEC filing
Mar 31, 2011Initial$150,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-157612

Source: Form D, filed Jun 28, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Yon Choi Executive
Brant Schofield Executive
Michael Steadman Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
1612 Summit Avenue, Suite 250
Fort Worth, TX, 76102